Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Naproxen
Wockhardt UK Ltd
M01AE02
Naproxen
250mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 10010100; GTIN: 5012727902937
CHANGE CONTROL : Version changes due to change in: Size/Layout Regulatory Non-Regulatory Changes in detail: • Regulatory text amends IN THIS LEAFLET: 1. What Naproxen Tablets are and what they are used for 2. What you need to know before you take Naproxen Tablets 3. How to take Naproxen Tablets 4. Possible side effects 5. How to store Naproxen Tablets 6. Contents of the pack and other information 1. What Naproxen Tablets are and what they are used for Naproxen belongs to a group of medicines called non-steroidal anti-inflammatory drugs (NSAID). It is a painkiller and antipyretic (reduces fever). Naproxen works by reducing inflammation and relieving pain, swelling and stiffness in the joints and muscles. There are a number of painful conditions that can affect your joints and muscles, which can be helped by taking Naproxen. These conditions include: • rheumatoid arthritis • juvenile rheumatoid arthritis • osteoarthritis • ankylosing spondylitis (arthritis in the spine) • acute gout • musculo-skeletal disorders such as sprains, back pains and fibrositis 2. What you need to know before you take Naproxen Tablets DO NOT TAKE NAPROXEN TABLETS: • if you are allergic to naproxen or any of the other ingredients of this medicine (listed in section 6) • if you have taken another non-steroidal anti-inflammatory drug before (including aspirin) and suffered an unpleasant or allergic reaction including asthma, redness and itching of the skin or an itchy, running nose • if you are taking Mifamurtide (used in anti-tumour treatment) • if you have or have had a history of recurrent stomach ulcer/bleeding or know that you have suffered with ulcers in the past • if you have serious problems with your liver, kidney or heart • if you are in the last three months of pregnancy WARNINGS AND PRECAUTIONS Talk to your doctor or pharmacist before taking Naproxen Tablets: • if you have any problems with your stomach or bowel • if you have problems with your liver or kidneys • if you have haemophilia or problems Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Naproxen 250mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Naproxen 250mg For excipients, see 6.1. 3 PHARMACEUTICAL FORM Tablet for oral use 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Naproxen is indicated for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, juvenile rheumatoid arthritis, acute gout and acute musculoskeletal disorders. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION For oral administration To be taken preferably with or after food._ _ Adults: Rheumatoid arthritis, osteoarthritis, ankylosing spondylitis: The usual dose is 500mg to 1g daily in two doses at 12 hour intervals. _Acute gout:_ The usual dose is 750mg initially followed by 250mg every eight_ _ hours until the attack has passed. _Acute musculoskeletal disorders: _The usual dose is 500mg initially followed by 250mg at 6-8 hour intervals up to a maximum daily dose after the first day of 1250mg. Elderly: Elderly: The elderly are at increased risk of the serious consequences of adverse reactions. If an NSAID is considered necessary, the lowest effective dose should be used and for the shortest possible duration. The patient should be monitored_ _regularly for GI bleeding during NSAID therapy. Children over 5 years: For the treatment of juvenile rheumatoid arthritis the usual dose is 10mg/kg daily in two doses at 12 hour intervals. Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.4). 4.3 CONTRAINDICATIONS Hypersensitivity to any of the constituents. NSAIDs are contraindicated in patients who have previously shown hypersensitivity reactions (e.g. asthma, rhinitis, angioedema or urticaria) in response to ibuprofen, aspirin, or other non-steroidal anti-inflammatory drugs. Severe hepatic, renal and cardiac failure (See section 4.4 – Special warnings and precautions for use). High doses of non-steroidal anti-inflammatory drugs are contraindicated wit Read the complete document